BioMarin Preps For Vimizim Launch, Its Largest Yet
This article was originally published in The Pink Sheet Daily
Executive Summary
The rare disease specialist is ramping up its commercial infrastructure and manufacturing capacity ahead of the launch of Vimizim, which could come in early 2014.